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doi:10.1016/j.jtcvs.2004.04.029420 The Journal of Thoracic and CardioObjective: Although sleeve segmentectomy for centrally located lung cancers was
originally designed for patients unable to tolerate lobectomy, we have tried it in
patients with noncompromised function as well. We evaluated the efficiency of this
atypical type of bronchoplasty.
Methods: Of 202 patients for whom we performed bronchoplasty for primary
non–small cell lung carcinoma, 16 underwent sleeve segmentectomy.
Results: Sixteen patients were classified into 4 groups according to the mode of
bronchial reconstruction: type A, anastomosis between the right intermediate or left
main and basal segmental bronchi with removal of the superior segment of the lower
lobe (S6; n  7); type B, anastomosis between the left main and lingular bronchi
with removal of the upper division of the left upper lobe (S123; n  3); type C,
anastomosis between the left main and upper division bronchi with removal of the
lingular segments (S45; n  4); and type D, others (n  2). Nine patients had
pulmonary function sufficient to tolerate lobectomy. The tumors were completely
resected in all patients. Combined performance of pulmonary angioplasty was
carried out in 2 patients. Bronchial reconstruction was successful in all patients, with
neither bronchial complications nor local recurrences. Ten patients had stage IA
disease, and 6 had more advanced disease. All patients were alive, except 1 who
died as a result of distant metastasis and 2 who died of noncancerous causes. Overall
3-year and 5-year survivals were 93.3% and 68.1%, respectively.
Conclusions: Sleeve segmentectomy, which is technically demanding, should be
considered in patients with centrally located and possibly curable early non–small
cell lung cancer because the prevalence of small-sized or multiple lung tumors has
been increasing and because our findings suggest that this lung-saving operation is
safe and useful.
The occurrence of lung cancer has recently been increasing, androutine clinical use of spiral or high-resolution computed tomogra-phy has made detection of many small pulmonary nodules possible.We have continued to doubt whether lobectomy, which has beengenerally accepted as a standard form of cure for primary non–smallcell lung cancer, is required for treatment of such small-sized le-
sions. Because lesser removal of lung parenchyma could be beneficial to patients,1-6
we have always considered pulmonary-saving procedures, even for treatment of
malignant lesions.7-10 We have in fact performed pneumonectomy in only 1.3% of
749 patients treated surgically in our institution for primary lung cancer from 1999
through 2003. In addition, bronchoplastic procedures, which were reported to be
usually adequate for around 5% of patients with resectable pulmonary malignan-
11,12 7,8cy, has been carried out in more than 10% of our patients.
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resection triggers an increase in locoregional recurrence and
death rate compared with lobectomy13 confirmed the latter
to be a standard procedure of choice for tumors of any size.
However, to undoubtedly accept their conclusions, of which
invited commentators had a poor opinion, is risky and
unfair, mainly because their trial included many cases of
wedge resection and not segmentectomy as a type of lesser
resection. Several studies, including prospectively per-
formed studies, have recently demonstrated the role of seg-
mentectomy for small-sized N0 cancer,5,14-18 and current
influential data thus suggest that segmentectomy for smaller
N0 cancers might be an acceptable mode of surgical treat-
ment, even for noncompromised patients. Sleeve segmen-
tectomy was originally designed for patients with compro-
mised lung function who were unable to tolerate lobectomy.
If segmentectomy yielded survival results at least equal to
those of lobectomy in addition to better functional results, it
could become an accepted procedure for patients who have
anatomically suitable tumors, regardless of lung function.
Functional lung parenchyma can be preserved, and the
reimplanted segments will contribute to postoperative qual-
ity of life. If a second primary lung cancer develops, sub-
sequent resection might be offered to selected patients. We
have aggressively performed various atypical types of bron-
chial reconstructions at the segmental level in patients with
noncompromised as well as compromised lung function.
Because there have been very few reports summarizing the
results of sleeve segmentectomy for lung cancer, we present
here its significance and results obtained on continued care-
ful follow-up.
Patients and Methods
Of 1760 patients who were operated on for primary non–small cell
lung cancer from January 1988 through December 2003, 202
(11.5%) underwent bronchoplastic procedures. Of them, 16 pa-
tients underwent sleeve segmentectomy, and we classified these
patients in 4 groups (A to D) in accordance with the manner of
bronchial reconstruction (Table 1).
Preoperative bronchoscopic examination was crucial in reveal-
ing the location and extent of the tumor because most of the cases
could not be viewed or palpated from outside of the bronchus
during the operation. Standard surgical technique was used for
14,15
TABLE 1. Type of procedure and reconstruction
Class Lung resection
Type A S6 Right interm
Left main b
Type B Left S123 Left main b
Type C Left S45 Left main b
Type D Unclassified (others)
S6, Superior segment of lower lobe; S123, upper division segments; Ssegmentectomy until the bronchus was encountered. Proximal
The Journal of Thoraciand distal points of transection at the bronchus were established
with at least 1 cm of macroscopically uninvolved distance. On the
basis of results of intraoperative frozen section evaluation of both
the margins, we possibly removed additional portions of the bron-
chus, as in case A-6 mentioned below in detail. Bronchial anasto-
mosis was performed with interrupted sutures and full-thickness
bites by using 4-0 monofilament absorbable material (polydiox-
anone suture, PDS-II; Ethicon, Tokyo, Japan), which was placed
and tied in order from the deepest point to the lateral direction. In
this type of bronchoplasty, there is generally a difference between
the proximal diameter of the bronchus and the distal bronchus,
which is quite thin and frail. However, the tissues there were
flexible enough that careful placement of sutures could compen-
sate for this discrepancy. A few adjusting stitches in the membra-
nous part of the larger stump can help to make the anastomosis
simpler to perform at the level of the main or lobar bronchi but not
at the level of the segmental bronchi, where there are a couple of
knacks for performing anastomosis. To prevent the anastomosis
from progressing to stenosis, it is recommended that suturing be
done to make the distal stump potentially enlarged as a mainstay of
the stronger oral stump and that the bites of suture stitches and the
intervals between each stitch, especially at the distal stump, be
relatively short, with care being taken that the sutures do not
compromise blood flow to the margins. Inside knotting of the
deepest stitches is helpful, even at distal levels beyond the lobar
bronchus.7 When combined performance of angioplasty of the
pulmonary artery was required, which was occasionally encoun-
tered in type C reconstructions, both bronchial and arterial anas-
tomotic sites must be detached. Vascular reconstruction with a
continuous 5-0 nonabsorbable polypropylene material (Prolene,
Ethicon) was performed after the bronchial reconstruction. Elec-
trocauterization or stapling (Endocutter; Ethicon Endo-Surgery,
Cincinnati, Ohio) was used to divide the intersegmental plane.
Dissection or sampling of the hilar and mediastinal nodes was
performed in noncompromised or compromised patients, respec-
tively.19 Resected specimens were examined histopathologically,
and histologic typing was performed according to World Health
Organization classification. Surgical-pathologic staging was per-
formed by using the New International Staging System for Lung
Cancer.20 For staging and evaluation of recurrence, we carried out
a physical examination, biochemical profile, chest radiographic
examination, bronchoscopy, bone scintigraphy, and computed to-
mography of the chest, brain, and upper portion of the abdomen.
Routine bronchoscopies were performed 1 and 6 months after the
Anastomosis Preservation
l bronchi–basal segmental bronchi Basal segments
i–basal segmental bronchi
i–lingular bronchi Left S45





45,operation to monitor the status of the anastomosis and to rule out
c and Cardiovascular Surgery ● Volume 128, Number 3 421
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atively at 3-month intervals for 5 years and thereafter at 1-year
intervals to check for recurrence and survival.21
Results
The clinical characteristics, surgical treatment, pathologic
stage, and prognosis of 16 patients in whom sleeve segmen-
tectomy was performed are summarized in Table 2. In
addition, illustrations of representative surgical procedures
are provided in Figure 1. On the basis of clinical and
objective functional assessment, 9 patients were considered
to have pulmonary function sufficient to tolerate lobectomy,
whereas the remaining 7 patients had poor functional re-
serve. There were 13 men and 3 women enrolled in the
study, with a mean age of 64 years (range, 20-76 years).
Overall follow-up ranged from 7 to 152 months, with a
median of 46 months. Histologic cell type was squamous
cell carcinoma in 13 (81%) patients, adenocarcinoma in 2
(13%) patients, and mucoepidermoid carcinoma in 1 (6%)
patient. Complete resection was performed in all patients.
Angioplasty of the pulmonary artery, so-called double-
sleeve resection, was performed in 2 patients classified as
type C. On surgical-pathologic staging, 10 (63%) patients
had stage IA disease, 1 had stage IB disease, 3 had stage IIA
disease, and 2 had stage IIB disease. There was no operative
mortality, which was defined as death within 30 days after
the operation. Postoperative complications were infrequent
TABLE 2. Case data
Type No. Sex Age (y)
Histologic
type Resected seg
A 1† M 74 SQ Left S6
2† M 58 SQ Right S6
3 M 62 AD Left S6
4 M 74 SQ Right S6
5 M 70 SQ Left S6
6† M 65 SQ Left S6
7 M 59 SQ Right S6
B 1 M 57 SQ Left S12
2† M 54 SQ Left S12
3† M 61 SQ Left S12
C 1† M 63 SQ Left S45
2† M 74 SQ Left S45
3* F 76 SQ Left S45
4* F 69 AD Left S45
D 1† M 75 SQ Left S12
2† F 20 ME Right S3
SQ, Squamous cell carcinoma; S6, superior segment of lower lobe; AD, a
S12, apical and posterior segments of upper lobe; ME, mucoepidermoid
*Double sleeve case (with pulmonary artery reconstruction).
†Patients with an adequate pulmonary function to tolerate lobectomy.
‡Noncancer cause.
§Distant metastasis.and nonfatal, with bacterial pneumonia and bronchial
422 The Journal of Thoracic and Cardiovascular Surgery ● Septasthma occurring in 1 patient each. In all patients bronchial
reconstruction was successful, and neither stenosis nor local
recurrence at the anastomotic site, reimplanted lung, or
regional lymph node involvement had developed by the
time of this report. However, 1 patient with stage IIB
disease died 2 years after the operation as a result of distant
metastasis, and 2 patients died of noncancerous causes.
Overall 3-year and 5-year survivals were 93.3% and 68.1%,
respectively.
Discussion
Generally, making the decision whether to perform bron-
choplasty for malignancy depends on a subtle balance
among postoperative quality of life, risk of recurrence, and
postoperative complications. One of the greatest concerns
about sleeve segmentectomy is the potentially increased rate
of local recurrence, although no local recurrence has oc-
curred in this series. In any case, it is essential to ensure a
macroscopically sufficient margin of safety, as well as to
examine it with rapid frozen sections intraoperatively. The
rate of postoperative complications, which were nonfatal
and minor respiratory problems, was generally low in the
present series, and survival after the operation was not poor.
Hilar lung cancer has a tendency to occur multicentrically,
and therefore the goal of radical surgical intervention should
be to maintain as much lung function as possible because
Pathologic Local
recurrence PrognosisT N M Staging
1 0 0 IA No 152 mo, alive
1 0 0 IA No 58 mo, dead‡
1 0 0 IA No 57 mo, alive
2 0 0 IB No 53 mo, dead‡
1 1 0 IIA No 39 mo, alive
1 0 0 IA No 38 mo, alive
2 1 0 IIB No 35 mo, alive
1 1 0 IIA No 75 mo, alive
1 0 0 IA No 65 mo, alive
1 0 0 IA No 35 mo, alive
1 0 0 IA No 103 mo, alive
1 0 0 IA No 41 mo, alive
2 1 0 IIB No 24 mo, dead§
1 1 0 IIA No 7 mo, alive
1 0 0 IA No 70 mo, alive
1 0 0 IA No 39 mo, alive
carcinoma; S123, upper division segments; S45, lingular segments;





carcthe initial mode of the operation influences the resectability
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TSof secondary disease. We have carried sleeve segmentec-
tomy actively not only in compromised patients but also in
noncompromised patients. In the latter group, if an intraop-
erative pathologic examination points out that the disease
can be advanced, the procedure will be modified to the
standard one, such as lobectomy or sleeve lobectomy, with
complete systematic dissection of the lymph nodes. Most
surgeons might have chosen lobectomy for the noncompro-
mised patients and not performed thoracotomy for the com-
promised patients in this series. Sleeve segmentectomy, for
which hilar cancer with negative nodes is the most suitable
indication, should be considered, even for noncompromised
patients. Two representative cases will be presented. One
patient (case A-6; Figure 1, A) intentionally underwent left
sleeve S6 (superior segment of lower lobe) segmentectomy
with partial resection of the upper lobe bronchus because his
disease had invaded beyond the second carina. In addition,
the distal bronchial stump was trimmed with convex wedge-
shaped cutting to complete the anastomosis because the
lesion also involved the bronchial wall toward the basal
segment. The other patient (case C-4; Figure 1, B) under-
went sleeve lingulectomy (S45) with sleeve angioplasty
of the pulmonary artery, so-called double-sleeve resection.
To our knowledge, there have been no previous reports
concerning double-sleeve resection at the level of the seg-
ment. The artery was freed proximally and distally to allow
anastomosis without tension and reconstructed with a peri-
cardial patch. Because the patient’s preoperative values of
forced expiratory volume in 1 second and forced expiratory
volume in 1 second/forced vital capacity were 0.85 L and
37%, respectively, high-frequency jet ventilation was ap-
plied to inflate the left upper division segments detached
during the procedure of anastomosis, accompanied by in-
termittent positive-pressure ventilation to the right lung.
These patients have recovered uneventfully. Endobron-
chial interventions, such as YAG laser cauterization,
brachytherapy, and photodynamic therapy, can be therapeu-
tic options for very early hilar cancer located at sites that
can be directly viewed with a bronchoscope. These tech-
niques, however, cannot accurately address the depth of
invasion, free margins, or nodal status, and complete remis-
sion can be obtained only in carcinoma in situ or microin-
vasive cancer. We believe that except for selected patients
in whom radical treatment can definitely be performed with
these endoluminal interventions, thoracotomy is more reli-
able at present. When segmentectomy, with or without
bronchoplasty, is planned in noncompromised patients, dis-
sected lymph nodes should undergo intraoperative frozen-
section pathologic examination to confirm the absence of
metastasis because this information is needed for a diagno-
sis of early cancer. The results of this study clearly demon-
strate that sleeve segmentectomy is a satisfactory surgical
The Journal of Thoracioption for hilar lung cancer, as regards both operative risk
and curability. The indications for this procedure, which is
technically more demanding than lobectomy, need to be
thoroughly clarified. We suggest that sleeve segmentectomy
should be considered an option for small-sized, centrally
Figure 1. Schematic illustrations of representative surgical find-
ings. A, Case A-6: left sleeve S6 (superior segment of lower lobe)
segmentectomy with additional deep wedge resection of the
second carina caused by involvement of the lesion. The distal
bronchial stump was trimmed with convex wedge-shaped cutting
because the lesion also extended to the basal segmental bron-
chus. B, Case C-4: left sleeve lingulectomy (S45) with a side-
to-end anastomosis between the left main and the cut end of the
upper division of the bronchi, and sleeve resection of the pulmo-
nary artery with subsequent reconstruction using a pericardial
patch (so-called double-sleeve resection).located, N0 non–small cell lung cancer when feasible.
c and Cardiovascular Surgery ● Volume 128, Number 3 423
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